Idiopathic Type 1 diabetes

Journal of Diabetes and its Complications

Volumn 15, Issue 6, 2001, Pages 328-335

  Piñero Piloña, Antonio ^a   Raskin, Philip ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; LIPID; TRANSCRIPTION FACTOR;

DIABETIC KETOACIDOSIS; DISEASE COURSE; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INCIDENCE; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DISEASE; METABOLISM; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TOXICITY; UNITED STATES; URBAN AREA;

BLOOD GLUCOSE; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 0035172952     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00172-6     Document Type: Review

References (52)

1. Ketosis-onset diabetes in young adults with subsequent non-insulin dependency, a link between IDDM and NIDDM
2. Ketoacidosis-onset non-insulin dependent diabetes in Japanese subjects
3. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus
4. Mechanism of disease: The pathogenesis of insulin dependent diabetes mellitus
5. The relationship between immune-mediated Type 1 diabetes mellitus and ethnicity
6. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with Type 2 diabetes mellitus
7. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4, Flatbush Diabetes
8. Missense mutation Gly574Ser in the transcription factor HNF-1alpha is a marker of atypical diabetes mellitus in African-American children
9. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen in Type 2 diabetes
10. Pathophysiology of Type 2 diabetes and modes of action of therapeutic interventions
11. The triumvirate: β-cell, muscle, liver, a collusion responsible for NIDDM
12. Gender differences in insulin-stimulated glucose utilization among African-Americans
13. Gender differences in the relationship between insulin mediated glucose utilization and sex hormones in young African-Americans
14. The metabolic derangements and treatment of diabetic ketoacidosis
15. Atypical ketoacidosis in Type 2 diabetes
16. Role of free fatty acids and insulin in determining free fatty acids and lipids oxidation in man
17. Effects of insulin on oxidative and non-oxidative pathways of free fatty acid metabolism in human obesity
18. Diminished insulin sensitivity and increased insulin response in nonobese nondiabetic Mexican Americans
19. A novel subtype of Type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
20. Diabetes genes in non-insulin dependent diabetes mellitus
21. Impaired glucose tolerance as a disorder of insulin action, longitudinal and cross sectional studies in Pima Indians
22. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus: Prospective studies of Pima Indians
23. Fatty acids, lipotoxicity and insulin secretion
24. Mechanism of liver and muscle insulin resistance induced by high fat feeding
25. Metabolic defects in lean nondiabetic offspring of NIDDM parents: A cross-sectional study
26. Idiopathic Type 1 diabetes in Dallas, Texas; a five-year experience
27. Diabetic ketoacidosis among obese African-adolescents with NIDDM
28. The importance of a name
29. Non-insulin dependent diabetes mellitus: A genetically programmed failure of the beta cell to compensate for insulin resistance
30. Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain Acyl-CoA implicated in multiple tissue defects of obesity and NIDDM
31. Differentiating glucose toxicity from glucose desensitization: A new message from the insulin gene
32. Mechanism of free fatty acid-induced insulin resistance in humans
33. Characteristics of youth-onset non-insulin dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis
34. Glucose transporters and insulin action: Implications for insulin resistance and diabetes mellitus
35. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
36. In vivo beta cell function at the transition to early non-insulin diabetes mellitus
37. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus
38. Insulin resistance or insulin deficiency, which is the primary cause of IDDM?
39. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: Observation during eligibility testing for the Diabetes Control and Complications Trial (DCCT)
40. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
41. Effects of intensive therapy on residual β-cell function in patients with Type 1 diabetes in the Diabetes Control and Complications Trial
42. Report of the expert committee on the diagnosis and classification of diabetes mellitus
43. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33)
44. Diabetic ketoacidosis in obese African-Americans
45. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-Americans with a history of hyperglycemic crisis
46. Hyperglycemic crises in urban blacks
47. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
48. Slow glucose removal rate and hyperinsulinemia precede the development of Type 2 diabetes in the offspring of diabetic parents
49. Ketoacidosis in apache Indians with non-insulin dependent diabetes mellitus
50. Maturity onset diabetes of youth in black Americans
51. Clinical characteristics and outcomes of hyperglycemic emergencies in Johannesburg Africans